Ultra-low-dose Radiation Therapy Followed by Orelabrutinib as First-line Treatment for Stage Ⅰ-Ⅱ MALT Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ultra-low-dose Radiation Therapy Followed by Orelabrutinib as First-line Treatment for Stage Ⅰ-Ⅱ MALT Lymphoma	B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 2	2026-05-11		NCT07554898

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Changxing County Traditional Chinese Medicine Hospital	2
First Affiliated Hospital of Zhejiang University	201
Second Affiliated Hospital, Zhejiang University, School of Medicine	561
Zhejiang Cancer Hospital	142
Zhejiang Provincial People's Hospital	74
Zhejiang Provincial Tongde Hospital	20

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No. 1, East Banshan Road , Gongshu District	Hangzhou	China	1
The First Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	China	39